Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis

Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis

Bibliographic Details
Main Authors:	Hatano, H, Shaw, J, McHugh, K, Bowness, P, Kollnberger, S
Format:	Conference item
Published:	2013

Similar Items

Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis
by: Ridley, A, et al.
Published: (2016)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
by: Kollnberger, S, et al.
Published: (2012)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
by: Rysnik, O, et al.
Published: (2012)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
by: Ridley, A, et al.
Published: (2013)

HLA-B-27 heavy chain homodimer formation and natural killer cell family interaction - comparison of two HLA-B-27 subtypes in vitro
by: Giles, J, et al.
Published: (2008)

THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09
by: Shaw, J, et al.
Published: (2013)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
by: Kollnberger, S, et al.
Published: (2007)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
by: Giles, J, et al.
Published: (2010)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
by: Hatano, H, et al.
Published: (2013)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
by: Rysnik, O, et al.
Published: (2012)

The role of HLA-B27 in the pathogenesis of spondyloarthritis
by: McHugh, K
Published: (2011)

Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis.
by: Chan, A, et al.
Published: (2005)

The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
by: Kollnberger, S, et al.
Published: (2009)

Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis
by: Chan, A, et al.
Published: (2005)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
by: McHugh, K, et al.
Published: (2014)

KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis.
by: Wong-Baeza, I, et al.
Published: (2013)

KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
by: Wong-Baeza, I, et al.
Published: (2013)

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
by: Chan, A, et al.
Published: (2005)

HLA-B*2709 FORMS LESS CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN ARTHRITIS-ASSOCIATED HLA-B*2705
by: Shaw, J, et al.
Published: (2012)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
by: Kollnberger, S, et al.
Published: (2010)

HD6: a novel monoclonal antibody that recognises a subset of HLA-B27 molecules strongly implicated in spondyloarthritis disease pathogenesis
by: McHugh, K, et al.
Published: (2011)

HD6: A NOVEL MONOCLONAL ANTIBODY THAT RECOGNISES A SUBSET OF HLA-B27 MOLECULES STRONGLY IMPLICATED IN SPONDYLOARTHRITIS DISEASE PATHOGENESIS
by: McHugh, K, et al.
Published: (2011)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue
by: Rysnik, O, et al.
Published: (2016)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
by: Kollnberger, S, et al.
Published: (2004)

The role of HLA-B27 in spondyloarthritis.
by: Allen, R, et al.
Published: (1999)

The role of cell surface HLA-B27 heavy chain homodimer interactions with NK receptors in the pathogenesis of spondyloarthritis
by: Kollnberger, S
Published: (2005)

HLA-B27 FORMS HEAVY CHAIN HOMODIMERS IN VITRO AND IN VIVO THAT BIND TO CELLULAR RECEPTORS INCLUDING LILR AND KIR FAMILY MEMBERS
by: McHugh, K, et al.
Published: (2010)

The pathogenesis of spondyloarthritides - HLA-B-27 homodimer expression on human monocyte/macrophage cell lines
by: McHugh, K, et al.
Published: (2008)

Direct visualisation of HLA-B27 forms in cell lines and Spondyloarthropathy tissues
by: Rysnik, O, et al.
Published: (2013)

The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
by: Cauli, A, et al.
Published: (2013)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
by: Kollnberger, S, et al.
Published: (2007)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.
by: Shaw, J, et al.
Published: (2012)

Functional characterisation of HLA-B27 in autoimmunity
by: Kollnberger, S, et al.
Published: (2001)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
by: Kollnberger, S, et al.
Published: (2010)

PHENOTYPIC CHARACTERIZATION OF NATURAL KILLER CELLS AND RECEPTORS IN SPONDYLOARTHRITIS
by: Chan, A, et al.
Published: (2004)

Identification and characterisation of cell surface HLA-B27 homodimers
by: Bird, L, et al.
Published: (2002)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
by: McMichael, A, et al.
Published: (2002)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
by: Jacqueline eShaw, et al.
Published: (2012-11-01)

The biochemistry and immunology of non-canonical forms of HLA-B27
by: Shaw, J, et al.
Published: (2014)